Products
Companies
News
About
About
FAQ
Contact
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
SenseCare-Lung Pro
SenseCare-Lung Pro
SenseTime
SenseCare Lung CT automatically detects pulmonary nodules and pneumonia (including COVID-19) lesions and provides analysis such as lesion classification, risk evaluation, quantification, and structured reports for radiologists. Based on 3D rendering technology, it can also provide a 3D reconstruction.
Information source:
Vendor
Last updated:
August 26, 2021
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
SenseCare-Lung Pro
Company
SenseTime
Subspeciality
Chest
Modality
CT
Disease targeted
Lung cancer, pneumonia, COVID-19
Key-features
Lung nodule detection, nodule type classification (solid, GGO etc.), pneumonia detection, key parameter quantification, nodule tracking over time, automatic report generation
Suggested use
During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion
Technical Specifications
Data characteristics
Population
All chest CTs, all ages
Input
Non enhanced CT, slice thickness compatible with <= 5mm, prefered <= 1.5mm
Input format
DICOM
Output
Image annotations, key parameter quantification, follow up analysis, report based on AI findings
Output format
DICOM
Technology
Integration
Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Stand-alone third party application, Stand-alone webbased
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis
Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
1 - 10 minutes
Regulatory
Certification
CE
Certified, Class IIb
, MDR
FDA
No or not yet
Intended Use Statements
Intended use (according to CE)
Market
Market presence
On market since
10-2020
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Pay-per-use, Subscription
Based on
Number of users, Number of installations, Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers